TrialNature cardiovascular research2023

Empagliflozin effects on iron metabolism as a possible mechanism for improved clinical outcomes in non-diabetic patients with systolic heart failure.

Christiane E Angermann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.